Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population

被引:0
|
作者
Moriyama, Kengo [1 ]
Inoue, Nagamu [1 ]
Imai, Jin [2 ]
Masuda, Yumi [3 ]
Yamada, Chizumi [3 ]
Kishimoto, Noriaki [3 ]
Takashimizu, Shinji [2 ]
Kubo, Akira [3 ]
Nishizaki, Yasuhiro [2 ]
机构
[1] Tokai Univ, Hachioji Hosp, Dept Clin Hlth Sci, Sch Med, Tokyo, Japan
[2] Tokai Univ, Dept Clin Hlth Sci, Sch Med, Hiratsuka, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Tokyo Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
metabolic dysfunction-associated fatty liver disease; triglyceride to high-density lipoprotein cholesterol ratio; alanine aminotransferase; insulin resistance; triglyceride-glucose index; annual health examination; HOMEOSTASIS MODEL ASSESSMENT; TRIGLYCERIDE-GLUCOSE INDEX; ETHNIC-DIFFERENCES; MANAGEMENT; PRODUCT;
D O I
10.1089/met.2023.0116
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Recently, metabolic dysfunction-associated fatty liver disease (MAFLD), which is based on evidence of hepatic steatosis and any of the following three conditions: overweight/obesity, presence of type 2 diabetes mellitus, or evidence of metabolic dysregulation, has been proposed. It is uncertain how indices that predict insulin resistance (IR) are associated with MAFLD. Methods: Among subjects who had undergone health examinations at our hospital, 1,257 (787 men and 474 women) who underwent fatty liver evaluation, were included in this cross-sectional study. The discriminatory ability of each index for MAFLD was tested using a receiver operating characteristic curve analysis. The associations between the homeostasis model assessment-IR (HOMA-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride-glucose (TyG) index, and MAFLD were investigated using multiple logistic regression analysis. Results: The mean age and body mass index of MAFLD subjects were 58.1 years and 26.0kg/m(2) in men and 63.0 years and 26.1kg/m(2) in women, respectively. The cutoff values of HOMA-IR, TG/HDL-C ratio, and TyG index in men and women were 1.40 (area under the curve [AUC]: 0.81) and 1.90 (AUC: 0.88); 1.56 (AUC: 0.75) and 1.06 (AUC: 0.78); and 8.62 (AUC: 0.75) and 8.45 (AUC: 0.80), respectively. All indices were significantly higher in both men and women with MAFLD. In the multivariate models, the odds of MAFLD were higher among both men and women in the highest tertile than those in the lowest tertile. When subjects were divided by sex, presence of MAFLD, and alanine aminotransferase (ALT) values, all indices were significantly higher in both men and women with high ALT levels who were diagnosed with MAFLD. Conclusion: IR strongly correlated with MAFLD, particularly in subjects with high ALT levels.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [11] Triglycerides to apolipoprotein A1 ratio: an effective insulin resistance-associated index in identifying metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
    Wang, Wei
    Chen, Yang
    Tu, Mei
    Chen, Hang Ju
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [12] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [13] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [14] Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
    Ziamanesh, Fateme
    Mohammadi, Mehdi
    Ebrahimpour, Sholeh
    Tabatabaei-Malazy, Ozra
    Mosallanejad, Asieh
    Larijani, Bagher
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (02) : 1083 - 1094
  • [15] Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
    Wang, Di
    Zhou, Bing-Yan
    Xiang, Lei
    Chen, Xu-Yong
    Feng, Jie-Xiong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (25) : 3132 - 3139
  • [16] Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
    Fateme Ziamanesh
    Mehdi Mohammadi
    Sholeh Ebrahimpour
    Ozra Tabatabaei-Malazy
    Asieh Mosallanejad
    Bagher Larijani
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 1083 - 1094
  • [17] Diet quality indices and odds of metabolic dysfunction-associated fatty liver disease: a case-control study
    Ramaiah, Pushpamala
    Baljon, Kamilya Jamel
    Alsulami, Sana A.
    Lindsay, Grace M.
    Chinnasamy, Lathamangeswari
    FRONTIERS IN NUTRITION, 2024, 10
  • [18] Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
    Xiao, Yuji
    Zhang, Xue
    Yi, Dongxin
    Qiu, Fangyi
    Wu, Lei
    Tang, Yiyong
    Wang, Ningning
    FRONTIERS IN NUTRITION, 2023, 10
  • [19] Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria
    Pan, Jie
    Ding, Yijie
    Sun, Yan
    Li, Qiuyan
    Wei, Tianyi
    Gu, Yingying
    Zhou, Yujia
    Pang, Nengzhi
    Pei, Lei
    Ma, Sixi
    Gao, Mengqi
    Xiao, Ying
    Hu, De
    Wu, Feilong
    Yang, Lili
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [20] Insulin resistance as a mediator in the association between nickel exposure and metabolic dysfunction-associated steatotic liver disease
    Liu, Zhou
    Zhang, Liang
    Wu, Yanrui
    Tan, Zongbiao
    Li, Guang
    Li, Zhenwen
    Zhan, Liying
    Dong, Weiguo
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01)